RECENT NEWS

Roche has announced the expansion of its digital pathology open environment with the integration of more than 20 advanced artificial intelligence (AI) algorithms from eight new collaborators. These strategic collaborations aim to support pathologists and scientists in cancer research and diagnosis by leveraging cutting-edge AI technology.

AI technology firm Paige has unveiled Alba, a clinical-grade multimodal co-pilot designed to revolutionise personalised medicine and precision oncology. Using the power of Paige’s Foundation Models, Alba delivers AI-driven patient insights in real-time and marks a significant step toward Artificial General Intelligence (AGI).

Proscia and Smart Reporting, a provider of medical documentation software, have partnered to help pathologists inform treatment decisions. The companies will deliver a unified experience around a product integration that enables pathologists to efficiently make and comprehensively report on precise diagnoses, all within a single user interface.

Artificial intelligence (AI)-powered cancer diagnostics firm Ibex Medical Analytics has unveiled the latest advancements in its innovative product platform, with an expanded focus on breast cancer.

Seegene and Springer Nature have joined forces to launch 'Nature Awards MDx Impact Grants in partnership with Seegene', a new project for the development of diagnostic assays. The program empowers researchers worldwide to develop innovative diagnostic assays using Seegene's advanced multiplex PCR technology.

Research supported by the National Institutes of Health has found that measuring two types of fat in the bloodstream along with C-reactive protein (CRP), a marker of inflammation, can predict a woman’s risk for cardiovascular disease decades later.

AMLo Biosciences has announced the successful receipt of the UKCA mark for AMBLor, a groundbreaking histopathological biomarker test for the personal identification of early-stage melanomas at low risk of progression, post staging diagnosis.

In response to disparities in cervical cancer screening, IBMS and BD unveil a report advocating for self-sampling and innovative technologies to ensure equitable access and improve health outcomes.

A lung cancer patient at University College London Hospitals (UCLH) is the first to receive a novel cancer vaccine that primes the immune system to recognise and fight cancer cells.

The Health and Care Professions Council (HCPC) has launched its revised standards of conduct, performance and ethics, which came into effect on 1 September.

NHS patients will have earlier access to new treatments and the UK will become the home of cutting-edge health research as the UK government launches a joint public-private investment programme worth up to £400 million.

Indica Labs, a provider of computational pathology software, and AI technology firm Paige have formed a non-exclusive partnership aimed at integrating Paige’s diagnostic AI models into Indica’s anatomic pathology workflow management software, HALO AP.

SYNLAB, has been chosen as the preferred supplier for the delivery of a single, outsourced pathology service to the Mid and South Essex NHS Foundation Trust. Used by all GPs in the region as well as Southend, Basildon and Broomfield hospitals, this service will include blood, tissue and other sample testing as well as the operation of phlebotomy clinics.

Clinical microbiology diagnostics firm QuantaMatrix has announced the development of 'uRAST' (Ultra-Rapid Antimicrobial Susceptibility Testing), the world’s fastest all-in-one antimicrobial testing technology.

StatLab Medical Products has announced that it has reached an agreement to acquire Diapath, an Italian manufacturer of histology and cytology products and equipment.

A $5.8 million grant led by Adrie Steyn PhD, of the University of Alabama at Birmingham and the Africa Health Research Institute (AHRI) in Durban, South Africa, will provide user-requested infected human lung tissue and analytical services to tuberculosis researchers worldwide.

The World Health Organization (WHO) has launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox through coordinated global, regional, and national efforts. This follows the declaration of a public health emergency of international concern by the WHO Director-General.

Scientists at the University of Nottingham are scaling up the development of a new Zika virus DNA vaccine thanks to a new collaboration with specialist company Touchlight, which will provide new technology to produce large quantities of the DNA vaccine at speed.

Blood packs have been successfully flown by drone in a series of ‘beyond visual line of sight’ flights, for the first time in the UK. This is the first in a series of NHS trials as part of a study to ascertain the feasibility and safety of delivering medical supplies via drone.

PreciseDx, a leading innovator in oncology diagnostics leveraging artificial intelligence (AI) for new, morphology-driven disease analysis, has announced that it has raised $20.7 million in Series B funding, bringing its total funding to date to $31.5 million.